Public Health Emergency - Leading a Nation Prepared
In the event of an anthrax attack, healthcare professionals will need to quickly determine who has been infected. Rapid diagnostics would enable public health professionals with critical information to guide triaging decisions and patient care in an emergency.
BARDA is supporting the advanced development of the following anthrax diagnostic products and platforms:
BARDA is interested in supporting the advanced development, clinical evaluation, and FDA clearance or approval of rapid, accurate point of care diagnostic systems for anthrax infection that are at a
Technology Readiness Level of 4 or higher. To learn more, see the
BARDA Broad Agency Announcement (AOI 7.2).
Home | Contact Us | Accessibility | Privacy Policies | Disclaimer | HHS Viewers & Players | HHS Plain Language
Assistant Secretary for Preparedness and Response (ASPR), 200 Independence Ave., SW, Washington, DC 20201
U.S. Department of Health and Human Services | USA.gov |
HealthCare.gov in Other Languages